ALPHYN BIOLOGICS, INC.

Profile

Company Names

ALPHYN BIOLOGICS, INC.
ALPHYN BIOLOGICS, LLC

Addresses

3724 THOMAS POINT ROAD, ANNAPOLIS, MD 21403

3724A THOMAS POINT ROAD, ANNAPOLIS, MD 21403

Phone Numbers

(443) 994-0101

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$9,328,198.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-03-28 
$5,172,484.00 
$5,172,484.00 
$0.00 
Equity 
3
2023-05-19 
$1,185,717.00 
$1,759,988.00 
$574,271.00 
Equity 
2
2022-05-19 
$2,169,997.00 
$3,499,999.00 
$1,330,002.00 
Equity 
1
2020-01-27 
$800,000.00 
$1,500,000.00 
$700,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROGER 
 
GRIGGS 
DIRECTOR
MEDELLA SPRINGS, LLC   |  ALPHYN BIOLOGICS, INC.
NEAL 
 
KOLLER 
EXECUTIVE OFFICER, DIRECTOR
PERTHERA, INC.   |  ALPHYN BIOLOGICS, LLC   |  ALPHYN BIOLOGICS, INC.
JEFFREY 
 
KOSSAK 
DIRECTOR
ALPHYN BIOLOGICS, INC.
ADEL 
 
MIKHAIL 
DIRECTOR
ALPHYN BIOLOGICS, INC.
GARY 
 
PEKOE 
EXECUTIVE OFFICER, DIRECTOR
ALPHYN BIOLOGICS, LLC   |  ALPHYN BIOLOGICS, INC.
STEVEN 
 
PENTELNIK 
DIRECTOR, EXECUTIVE OFFICER
ALPHYN BIOLOGICS, LLC   |  ALPHYN BIOLOGICS, INC.
TONY 
 
SHIPLEY 
DIRECTOR
QCA FIRST FUND III, LLC   |  CHARLES H MACK + ASSOCIATES INC   |  RHINOCYTE INC   |  BEAM TECHNOLOGIES, INC.   |  QCA FIRST FUND V LLC   |  QCA FIRST FUND VI LLC   |  ALPHYN BIOLOGICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-19 
2024-04-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-28 
2022-05-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-19 
2020-02-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-01-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#